The GSK UK Group has informed GlaxoSmithKline Consumer Nigeria PLC of its strategic intent to cease commercialization of its prescription medicines and vaccines in Nigeria.
Browsing: GlaxoSmithKline
By Hadiza Mohammed-Aliyu As the world gets set to mark the 2022 World Malaria Day (WMD), there is the need…
British pharmaceuticals producer GlaxoSmithKline has agreed to buy late-stage biopharmaceutical company Sierra Oncology. GlaxoSmithKline said on Wednesday that it would…
By Abujah Racheal The Society for Family Health (SFH) has said that the RTS,S/AS01 (RTS,S) malaria vaccine for children in…
Sanofi and GlaxoSmithKline announced the initiation of a new phase 2 study to select the most appropriate antigen dosage for…
British pharmaceuticals company GlaxoSmithKline and German vaccine developer CureVac announced collaboration on Wednesday to create next generation COVID-19 vaccines to…
British pharmaceutical firm GlaxoSmithKline (GSK) on Wednesday signed a product transfer agreement for malaria vaccine with Bharat Biotech (BBIL) of…
Transactions on the Nigerian Stock Exchange (NSE) remained upbeat on Tuesday with the market capitalisation hitting N17 trillion benchmark due…